Core Laboratories Inc. (CLB) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 27	$0.09	$0.11	+22.2%	—	—	—
Q4 26	$0.11	$0.06	-45.5%	—	—	—
Q3 26	$0.19	$0.21	+10.5%	—	—	—
Q2 26	$0.19	$0.22	+15.8%	—	—	—
Q1 26	$0.18	$0.19	+5.6%	—	—	—
Q4 25	$0.15	$0.14	-6.7%	—	—	—
Q3 25	$0.22	$0.22	0.0%	—	—	—
Q2 25	$0.23	$0.25	+8.7%	—	—	—
Q1 25	$0.22	$0.22	0.0%	—	—	—
Q4 24	$0.15	$0.19	+26.7%	—	—	—
Q3 24	$0.19	$0.19	0.0%	—	—	—
Q2 24	$0.22	$0.22	0.0%	—	—	—
Q1 24	$0.2	$0.21	+5.0%	—	—	—
Q4 23	$0.16	$0.19	+18.8%	—	—	—
Q3 23	$0.2	$0.2	0.0%	—	—	—
Q2 23	$0.15	$0.18	+20.0%	—	—	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$0.64	—	—	$526.5M	—
FY24	—	$0.67	—	—	$523.8M	—
FY23	—	$0.87	—	—	$509.8M	—
FY22	—	$0.42	—	—	$489.7M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$590.2M	$647.8M	$700.8M	$668.2M	$487.3M	$470.3M	$489.7M	$509.8M	$523.8M	$526.5M
YoY change	-26%	+9.76%	+8.19%	-4.66%	-27.1%	-3.49%	+4.14%	+4.1%	+2.76%	+0.51%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	590.2M	647.8M	700.8M	668.2M	487.3M	470.3M	489.7M	509.8M	523.8M	526.5M
Cost of revenue	463.8M	489.5M	520.1M	518.2M	395.6M	386.4M	410.8M	415.7M	435.5M	432.2M
Gross profit	126.4M	158.3M	180.8M	150M	91.6M	83.8M	78.9M	94M	88.4M	94.3M
Gross margin	21.4%	24.4%	25.8%	22.5%	18.8%	17.8%	16.1%	18.4%	16.9%	17.9%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	39.4M	47.7M	62.9M	48M	34M	43.9M	37.6M	38.9M	38.6M	44.2M
Operating expenses	39.4M	47.7M	62.9M	53.6M	38M	43.9M	37.6M	38.9M	38.6M	44.2M
Operating income	87.1M	110.6M	117.9M	102M	57.6M	40M	41.3M	55.2M	49.8M	50.5M
Operating margin	14.7%	17.1%	16.8%	15.3%	11.8%	8.5%	8.44%	10.8%	9.5%	9.59%
Non-operating income, net	400K	-632K	737K	-5.3M	-134.4M	5.3M	177K	-515K	8.8M	6M
Pretax income	75.9M	99.2M	105.3M	82M	-91.2M	36.1M	30M	41.2M	46.2M	45.9M
Income tax	10.9M	18.2M	25.4M	-12.3M	5.9M	15.9M	10.3M	4.2M	14M	15.5M
Net income	63.9M	83.1M	79.8M	102.1M	-97.5M	20.2M	19.7M	37M	32.2M	30.4M
Net margin	10.8%	12.8%	11.4%	15.3%	-20%	4.3%	4.01%	7.26%	6.14%	5.77%
EBITDA	115.5M	136.2M	143.1M	126.3M	79.5M	59.9M	60.5M	72.5M	67.3M	65.7M
EPS	1.45	1.88	1.79	2.29	-2.19	0.43	0.42	0.87	0.67	0.64
Diluted EPS	1.45	1.88	1.79	2.28	-2.2	0.42	0.42	0.86	0.66	0.63

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	125.3M	128.2M	129.6M	130.6M	134.4M	129.2M	123.6M	130.2M	134.5M	138.3M	121.8M	124.6M
Cost of revenue	100.5M	105.4M	108.4M	106.7M	110.5M	109.9M	103.2M	107.4M	108.5M	113.2M	105.8M	105.2M
Gross profit	24.8M	22.8M	21.2M	23.9M	23.9M	19.4M	20.4M	22.8M	26M	25.1M	16M	19.4M
Gross margin	19.8%	17.8%	16.4%	18.3%	17.8%	15%	16.5%	17.5%	19.3%	18.1%	13.1%	15.6%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	9.1M	8.3M	11.5M	10.3M	8.3M	8.8M	13.4M	10.5M	10.7M	9.4M	14.7M	11M
Operating expenses	9.1M	8.3M	11.5M	10.3M	8.3M	8.8M	13.4M	10.5M	10.7M	9.4M	14.7M	11M
Operating income	15.7M	14.5M	9.7M	13.6M	15.6M	10.6M	7M	12.3M	15.3M	16.1M	1.2M	8.5M
Operating margin	12.5%	11.3%	7.49%	10.4%	11.6%	8.19%	5.69%	9.47%	11.4%	11.6%	1.02%	6.79%
Non-operating income, net	-1M	54K	-1.1M	2.4M	4.2M	3.6M	-2.6M	3M	5.6M	-242K	645K	691K
Pretax income	11.5M	11M	5.1M	12.8M	16.7M	11.5M	1.8M	12.6M	18.3M	13.2M	-1M	6.3M
Income tax	2.3M	8.5M	1.7M	3.6M	4.7M	4.1M	1.7M	1.9M	3.8M	8.1M	-251K	507K
Net income	9.2M	2.4M	3.5M	9.2M	12M	7.5M	69K	10.7M	14.5M	5.1M	-753K	5.8M
Net margin	7.36%	1.9%	2.69%	7.04%	8.93%	5.78%	0.06%	8.2%	10.8%	3.71%	-0.62%	4.65%
EBITDA	19.9M	18.8M	13.8M	18.6M	20.4M	14.5M	11.6M	16.2M	19.4M	18.5M	5.7M	12.8M
EPS	0.2	—	0.07	0.19	0.25	0.16	0	0.23	0.31	0.16	-0.02	0.13
Diluted EPS	0.19	—	0.07	0.19	0.25	0.15	0	0.23	0.3	0.15	-0.02	0.12

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	5.3B	4.8B	2.6B	1.7B	1.2B	1B	945.2M	827.5M	810.6M	744.2M	460.2M
Enterprise value	5.5B	5.1B	2.9B	2B	1.5B	1.3B	1.2B	1B	971.6M	885.5M	625.2M
Shares outstanding	44.2M	44.2M	44.3M	44.5M	44.6M	46.3M	46.6M	46.9M	46.8M	46.4M	46.4M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	83	58.3	33.1	16.4	—	51.1	48.1	22.3	25.2	24.5	19.7
P/S	8.98	7.47	3.77	2.51	2.43	2.2	1.93	1.62	1.55	1.41	0.9
P/B	34.1	32.5	16.4	9.2	15.6	6.42	5	3.6	3.14	2.73	1.72
EV/EBITDA	47.6	37.1	20.4	16.2	18.8	21.2	19	14.2	14.4	13.5	10.9
EV/Sales	9.32	7.8	4.17	3.06	3.07	2.69	2.35	2.02	1.85	1.68	1.2
Earnings yield	1.2%	1.72%	3.02%	6.1%	—	1.96%	2.08%	4.47%	3.97%	4.08%	5.08%
FCF yield	2.27%	2.17%	3.36%	4%	3.85%	2.2%	1.56%	1.72%	5.35%	3%	7.82%
PEG	—	—	—	—	—	—	—	—	—	—	-0.46

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	21.4%	24.4%	25.8%	22.5%	18.8%	17.8%	16.1%	18.4%	16.9%	17.9%	15.6%
Operating margin	14.7%	17.1%	16.8%	15.3%	11.8%	8.5%	8.44%	10.8%	9.5%	9.59%	7.36%
Net margin	10.8%	12.8%	11.4%	15.3%	-20%	4.3%	4.01%	7.26%	6.14%	5.77%	4.69%
ROE	41.1%	55.9%	49.6%	56.1%	-129%	12.6%	10.4%	16.1%	12.5%	11.2%	9.05%
ROA	11.1%	14.2%	12.3%	13.2%	-17.1%	3.48%	3.4%	6.31%	5.45%	5.2%	4.45%
ROIC	20.9%	25%	20.4%	18.5%	14.8%	5.69%	6.85%	11.5%	8.28%	8.08%	6.55%
Return on tangible assets	32.7%	40%	43.4%	32.6%	-27.7%	5.53%	5.39%	9.91%	8.49%	8.48%	6.83%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.79	2.06	2.25	1.98	1.85	2.08	2.05	2.53	2.32	2.02	2.12
Quick ratio	1.47	1.73	1.81	1.53	1.42	1.58	1.47	1.72	1.71	1.51	1.55
Debt / equity	1.39	1.53	1.8	2.1	4.33	1.55	1.18	0.94	0.7	0.6	0.59
Debt / assets	0.38	0.39	0.45	0.49	0.58	0.43	0.38	0.37	0.31	0.28	0.28
Net debt / EBITDA	1.75	1.56	1.93	2.93	3.94	3.88	3.42	2.76	2.39	2.15	2.52
Interest coverage	7.56	10.2	8.9	6.58	-5.34	4.95	3.59	4.07	4.73	5.34	4.35
Effective tax rate	14.3%	18.4%	24.2%	0%	0%	44%	34.4%	10.2%	30.4%	33.8%	32.9%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	13.4	14.7	15.8	15	10.9	10.1	10.5	10.9	11.2	11.3	11.3
EPS (basic)	1.45	1.88	1.79	2.29	-2.19	0.43	0.42	0.87	0.67	0.64	0.64
EPS (diluted)	1.45	1.88	1.79	2.28	-2.2	0.42	0.42	0.86	0.66	0.63	0.52
Book value per share	3.52	3.37	3.63	4.1	1.7	3.47	4.05	4.9	5.5	5.86	5.94
FCF per share	2.72	2.38	2.01	1.51	1.02	0.49	0.32	0.3	0.93	0.48	0.23
Cash per share	0.33	0.33	0.3	0.25	0.31	0.38	0.33	0.32	0.41	0.49	0.49
Capex per share	—	—	—	—	—	—	—	—	—	0.31	0.37

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	—	—	—	—	—	—	—	—	—	2.77%	3.34%
Capex / operating cash flow	—	—	—	—	—	—	—	—	—	39.4%	61.4%
Payout ratio	149%	116.9%	121.9%	95.6%	-12.8%	9.07%	9.43%	5.05%	5.83%	6.15%	7.69%
Dividend yield	1.8%	2.01%	3.68%	5.83%	1.05%	0.18%	0.2%	0.23%	0.23%	0.25%	0.4%

Yield

0.4%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.01

ex-dividend Aug 10, 2026

Payout ratio

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 10, 2026	$0.01
May 11, 2026	$0.01
Feb 13, 2026	$0.01

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$125.3M	$128.2M	$129.6M	$130.6M	$134.4M	$129.2M	$123.6M	$130.2M	$134.5M	$138.3M	$121.8M	$124.6M
YoY change	-0.49%	+0.5%	+1%	+2.11%	+7.22%	+0.8%	-4.67%	-0.32%	+0.09%	+6.98%	-1.45%	-4.26%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	14.8M	14.4M	13.1M	11.1M	13.8M	17.7M	15.4M	15.1M	19.2M	22.7M
Receivables	114.3M	133.1M	129.2M	131.6M	83.2M	96.8M	106.9M	109.4M	111.8M	113.5M
Inventory	33.7M	33.3M	45.7M	50.2M	38.2M	45.4M	60.4M	71.7M	59.4M	54.5M
Total current assets	186.5M	207.4M	231M	221.2M	165.8M	189.1M	211.7M	223.1M	226.6M	214.7M
Property, plant & equipment	15.4M	7.8M	7M	82.9M	64.6M	52.3M	36.4M	32.9M	35.9M	30.3M
Goodwill & intangibles	378M	376.9M	464.9M	461.8M	216.1M	215.2M	213.9M	212.7M	211.7M	225.8M
Total assets	573.1M	584.8M	648.8M	774.7M	568.6M	580.9M	578.4M	586.4M	590.4M	584M
Accounts payable	33.7M	41.7M	41.2M	35.6M	23M	29.7M	45.8M	33.5M	34.5M	37.3M
Short-term debt	—	—	—	11.8M	11.4M	12.3M	11.7M	10.2M	10.7M	11.5M
Total current liabilities	104M	100.6M	102.5M	111.6M	89.8M	90.8M	103.1M	88.1M	97.6M	106M
Long-term debt	216.5M	227M	289.8M	369.9M	315.5M	237.9M	210.7M	205.2M	169.5M	152.6M
Total liabilities	417.8M	436.1M	487.9M	592.5M	493M	419.9M	389.4M	356.6M	332.7M	311.8M
Shareholders' equity	155.3M	148.7M	160.9M	182.1M	75.6M	161M	189M	229.8M	257.7M	272.2M
Total debt	216.5M	227M	289.8M	381.8M	327M	250.3M	222.4M	215.4M	180.1M	164M
Net debt	201.7M	212.6M	276.7M	370.7M	313.2M	232.6M	207M	200.3M	161M	141.3M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	16.6M	15.1M	14.9M	17.7M	21.5M	19.2M	22.1M	31.2M	25.6M	22.7M	22.8M	22.7M
Receivables	104.1M	109.4M	115.1M	115.6M	117.6M	111.8M	117M	113.9M	110.3M	113.5M	108.3M	108.8M
Inventory	75.1M	71.7M	70.7M	69.9M	65.5M	59.4M	59M	59.8M	58.2M	54.5M	57.8M	58M
Total current assets	228.5M	223.1M	229M	233.5M	235.2M	226.6M	228.8M	237.7M	226.9M	214.7M	214.4M	214.4M
Property, plant & equipment	152.6M	32.9M	152.2M	154.2M	154.3M	35.9M	155.4M	153M	152M	30.3M	154.7M	153.3M
Goodwill & intangibles	213.4M	212.7M	212.5M	212.2M	212M	211.7M	211.4M	212.3M	212.2M	225.8M	225.4M	225.1M
Total assets	592.4M	586.4M	588M	597.8M	600.5M	590.4M	591.5M	602.1M	591.4M	584M	587.7M	586.8M
Accounts payable	34.1M	33.5M	32.5M	36.9M	33.6M	34.5M	38.5M	41.7M	36.9M	37.3M	40M	40.2M
Short-term debt	9.8M	10.2M	10.4M	11M	11.4M	10.7M	11.7M	11.5M	11.5M	11.5M	12.1M	11.9M
Total current liabilities	84.3M	88.1M	85.5M	97.6M	94.9M	97.6M	103.7M	104.8M	95.7M	106M	104.7M	101M
Long-term debt	218.8M	205.2M	201.9M	190.2M	183.6M	169.5M	168.3M	167M	155.6M	152.6M	155.7M	153.2M
Total liabilities	363M	356.6M	350.5M	352.1M	344M	332.7M	332.2M	334.8M	314M	311.8M	312.6M	308M
Shareholders' equity	229.4M	229.8M	237.4M	245.7M	256.4M	257.7M	259.4M	267.3M	277.4M	272.2M	275.1M	278.8M
Total debt	228.6M	215.4M	212.3M	201.3M	195M	180.1M	180M	178.5M	167.1M	164M	167.8M	165.1M
Net debt	211.9M	200.3M	197.4M	183.6M	173.6M	161M	157.9M	147.4M	141.5M	141.3M	145M	142.4M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	63.9M	83.1M	79.8M	93.7M	-96.9M	20.2M	19.7M	37M	32.2M	30.4M
Depreciation & amortization	26.9M	24.5M	23.1M	22.6M	20.9M	18.5M	17.2M	15.8M	15M	14.6M
Stock-based compensation	22.1M	22.9M	34.2M	20.9M	7.4M	19.1M	7.8M	14M	3.8M	7.1M
Change in working capital	39.3M	2.8M	-13M	-19.3M	7.6M	-13.6M	-23.6M	-30.3M	11M	-10.6M
Operating cash flow	137.2M	136.5M	124.8M	78.4M	-74.8M	45M	25.9M	23.9M	54.3M	37M
Capital expenditure	—	—	—	—	—	—	—	—	—	-14.6M
Investing cash flow	-5.5M	-3.5M	-49M	99K	20.5M	4.4M	6.4M	3.9M	6.6M	-2.1M
Dividends paid	-95.1M	-97.1M	-97.3M	-97.6M	-12.4M	-1.8M	-1.9M	-1.9M	-1.9M	-1.9M
Share repurchases	-7.2M	-16.9M	-7.5M	-3.3M	-2.8M	-8.3M	-3.9M	-2.2M	-5.3M	-12.4M
Financing cash flow	-124.9M	-104.1M	-42.5M	-85.9M	-63M	-22.5M	-23.4M	-18.4M	-46M	-31.3M
Net change in cash	6.8M	28.9M	33.4M	-7.4M	-117.4M	26.9M	8.9M	9.3M	15M	3.7M
Free cash flow	120.2M	105.1M	88.9M	67.1M	45.5M	22.7M	14.7M	14.2M	43.4M	22.3M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	—	—	—	—	—	—	—	—	14.5M	5.1M	-753K	5.8M
Depreciation & amortization	—	—	—	—	—	—	—	—	3.6M	3.7M	3.8M	3.8M
Stock-based compensation	—	—	—	—	—	—	—	—	1.3M	1.1M	5M	902K
Change in working capital	—	—	—	—	—	—	—	—	-2.4M	-9.4M	1.6M	1.9M
Operating cash flow	—	—	—	—	—	—	—	—	8.5M	7.9M	4M	7.8M
Capital expenditure	—	—	—	—	—	—	—	—	-3M	-3.7M	-4.9M	-5.8M
Investing cash flow	—	—	—	—	—	—	—	—	2.4M	-3.6M	-3.4M	-3.9M
Dividends paid	—	—	—	—	—	—	—	—	-465K	-466K	-460K	-460K
Share repurchases	—	—	—	—	—	—	—	—	-5M	-2.7M	-4M	-2.7M
Financing cash flow	—	—	—	—	—	—	—	—	-16.5M	-7.1M	-457K	-3.8M
Net change in cash	—	—	—	—	—	—	—	—	-5.6M	-2.8M	108K	100K
Free cash flow	-3.7M	16.9M	2.5M	14.3M	10.4M	16.2M	3.1M	9.6M	5.5M	4.1M	-926K	2M

Date	Ratio
Jul 9, 2010	2:1
Dec 22, 1997	2:1

Core Laboratories Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history